The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Abbott Laboratories

NYSE: ABT
Last

(U.S.) $38.16

Today's change+0.26 +0.69%
Updated December 5 10:10 AM EST. Delayed by at least 15 minutes.
 

Abbott Laboratories

NYSE: ABT
Last

(U.S.) $38.16

Today's change+0.26 +0.69%
Updated December 5 10:10 AM EST. Delayed by at least 15 minutes.

Abbott Laboratories up (U.S.)$0.26

Abbott Laboratories is up today by (U.S.)$0.26 or 0.69% to (U.S.)$38.16. Over the last five days, shares have lost 1.50% and are down 15.03% for the last year to date. This security has underperformed the S&P 500 by 21.32% during the last year.

Key company metrics

  • Open(U.S.) $38.11
  • Previous close(U.S.) $37.90
  • High(U.S.) $38.25
  • Low(U.S.) $37.99
  • Bid / Ask(U.S.) $38.15 / (U.S.) $38.16
  • YTD % change-15.03%
  • Volume789,070
  • Average volume (10-day)8,842,032
  • Average volume (1-month)8,403,723
  • Average volume (3-month)8,944,684
  • 52-week range(U.S.) $36.00 to (U.S.) $46.22
  • Beta1.34
  • Trailing P/E57.39×
  • P/E 1 year forward17.17×
  • Forward PEG1.73×
  • Indicated annual dividend(U.S.) $1.04
  • Dividend yield2.73%
  • Trailing EPS(U.S.) $0.66
Updated December 5 10:10 AM EST. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2016Q2/2016Q1/2016Q4/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015
Revenue5,3025,3334,8855,188
Total other revenue--------
Total revenue5,3025,3334,8855,188
Gross profit3,0173,0522,7462,966
Total cost of revenue2,2852,2812,1392,222
Total operating expense4,4054,5174,3614,373
Selling / general / administrative1,6181,7461,6831,656
Research & development352348379375
Depreciation / amortization140145144143
Interest expense (income), net operating--------
Unusual expense (income)10-316-23
Other operating expenses, total--------
Operating income897816524815
Interest income (expense), net non-operating-117-103-58-41
Gain (loss) on sale of assets--------
Other--------
Income before tax-1797152830
Income after tax-35759956695
Income tax, total178116-54135
Net income-329615316767
Total adjustments to net income--------
Net income before extra. items-35759956695
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-35759956695
Inc. avail. to common incl. extra. items-329615316767
Diluted net income-329615316767
Dilution adjustment000--
Diluted weighted average shares1,4761,4801,4841,497
Diluted EPS excluding extraordinary itemsvalue per share-0.240.400.040.46
Dividends per sharevalue per share0.260.260.260.26
Diluted normalized EPSvalue per share-0.240.400.040.45